CMCX.L vs. MED
CMCX.L (CMC Markets plc) and MED (Medifast, Inc.) are both stocks. CMCX.L operates in Capital Markets (Financial Services), while MED operates in Personal Services (Consumer Cyclical). Over the past 10 years, CMCX.L returned 10.03%/yr vs -6.81%/yr for MED. At a 0.04 correlation, their price movements are largely independent.
Performance
CMCX.L vs. MED - Performance Comparison
Loading charts...
Different Trading Currencies
CMCX.L is traded in GBp, while MED is traded in USD. To make them comparable, the MED values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, CMCX.L achieves a 55.18% return, which is significantly higher than MED's 11.90% return. Over the past 10 years, CMCX.L has outperformed MED with an annualized return of 10.03%, while MED has yielded a comparatively lower -6.81% annualized return.
CMCX.L
- 1D
- 0.11%
- 1M
- 22.43%
- YTD
- 55.18%
- 6M
- 62.81%
- 1Y
- 93.05%
- 3Y*
- 46.87%
- 5Y*
- 3.69%
- 10Y*
- 10.03%
MED
- 1D
- -0.16%
- 1M
- -5.31%
- YTD
- 11.90%
- 6M
- -4.04%
- 1Y
- -7.26%
- 3Y*
- -47.81%
- 5Y*
- -45.33%
- 10Y*
- -6.81%
CMCX.L vs. MED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CMCX.L CMC Markets plc | 55.18% | 27.16% | 144.09% | -51.43% | -10.97% | -28.25% | 183.92% | 43.23% | -26.78% | 45.42% |
MED Medifast, Inc. | 11.90% | -43.71% | -73.33% | -41.42% | -35.45% | 10.40% | 80.71% | -13.17% | 92.91% | 57.43% |
Correlation
The correlation between CMCX.L and MED is 0.04, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.04 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.02 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.03 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Feb 5, 2016 | 0.04 |
Fundamentals
CMCX.L:
£1.30B
MED:
$130.86M
CMCX.L:
£0.50
MED:
-$1.82
CMCX.L:
1.69
MED:
0.38
CMCX.L:
2.84
MED:
0.66
CMCX.L:
£755.33M
MED:
$346.10M
CMCX.L:
£533.42M
MED:
$242.70M
CMCX.L:
£232.99M
MED:
-$3.86M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CMCX.L vs. MED — Risk / Return Rank
CMCX.L
MED
CMCX.L vs. MED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for CMC Markets plc (CMCX.L) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CMCX.L | MED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.29 | ||
| Sortino ratioReturn per unit of downside risk | +4.45 | ||
| Omega ratioGain probability vs. loss probability | 1.52 | 1.00 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 5.16 | -0.23 | +5.38 |
| Martin ratioReturn relative to average drawdown | 13.26 | -0.39 | +13.65 |
Loading charts...
Drawdowns
CMCX.L vs. MED - Drawdown Comparison
The maximum CMCX.L drawdown since its inception was -81.04%, smaller than the maximum MED drawdown of -96.56%. Use the drawdown chart below to compare losses from any high point for CMCX.L and MED.
Loading charts...
Drawdown Indicators
| CMCX.L | MED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -81.04% | -96.56% | +15.52% |
Max Drawdown (1Y)Largest decline over 1 year | -17.02% | -36.26% | +19.24% |
Max Drawdown (3Y)Largest decline over 3 years | -45.29% | -91.26% | +45.97% |
Max Drawdown (5Y)Largest decline over 5 years | -78.60% | -96.16% | +17.56% |
Max Drawdown (10Y)Largest decline over 10 years | -81.04% | -96.56% | +15.52% |
Current DrawdownCurrent decline from peak | -0.22% | -95.72% | +95.50% |
Average DrawdownAverage peak-to-trough decline | -40.52% | -39.64% | -0.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.63% | 21.00% | -14.37% |
Volatility
CMCX.L vs. MED - Volatility Comparison
CMC Markets plc (CMCX.L) has a higher volatility of 17.61% compared to Medifast, Inc. (MED) at 9.02%. This indicates that CMCX.L's price experiences larger fluctuations and is considered to be riskier than MED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CMCX.L | MED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.61% | 9.02% | +8.59% |
Volatility (6M)Calculated over the trailing 6-month period | 24.26% | 31.91% | -7.65% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.97% | 41.58% | +0.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 46.85% | 44.42% | +2.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.35% | 47.43% | -1.08% |
Dividends
CMCX.L vs. MED - Dividend Comparison
CMCX.L's dividend yield for the trailing twelve months is around 2.97%, while MED has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMCX.L CMC Markets plc | 2.97% | 4.62% | 4.19% | 4.67% | 5.53% | 9.46% | 5.47% | 2.41% | 6.94% | 5.95% | 0.00% | 0.00% |
MED Medifast, Inc. | 0.00% | 0.00% | 0.00% | 7.36% | 5.69% | 2.71% | 2.30% | 3.08% | 1.75% | 2.06% | 2.57% | 0.82% |
Financials
CMCX.L vs. MED - Financials Comparison
This section allows you to compare key financial metrics between CMC Markets plc and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CMCX.L vs. MED - Profitability Comparison
CMCX.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, CMC Markets plc reported a gross profit of 188.08M and revenue of 217.26M. Therefore, the gross margin over that period was 86.6%.
MED - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.
CMCX.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, CMC Markets plc reported an operating income of 57.64M and revenue of 217.26M, resulting in an operating margin of 26.5%.
MED - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.
CMCX.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, CMC Markets plc reported a net income of 38.42M and revenue of 217.26M, resulting in a net margin of 17.7%.
MED - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.
Frequently Asked Questions
CMCX.L and MED have a correlation of 0.04, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for CMCX.L and MED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer